Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

366 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
IL-17A inhibitor-induced pouchitis.
Kiyohara H, Mikami Y, Kanai T. Kiyohara H, et al. Clin Gastroenterol Hepatol. 2025 Jan 30:S1542-3565(25)00071-0. doi: 10.1016/j.cgh.2024.12.015. Online ahead of print. Clin Gastroenterol Hepatol. 2025. PMID: 39892631 No abstract available.
First-line biologics as a treatment for ulcerative colitis: a multicenter randomized control study.
Naganuma M, Shiga H, Shimoda M, Matsuura M, Takenaka K, Fujii T, Yamamoto S, Matsubayashi M, Kobayashi T, Aoyama N, Saito D, Yokoyama K, Moriya K, Tsuchiya K, Shibui S, Kawamoto A, Shimizu H, Okamoto R, Sakamoto K, Yaguchi K, Kunisaki R, Akiyama S, Hayashi R, Hasui K, Kanmura S, Bamba S, Mishima Y, Kakimoto K, Sugimoto S, Nakazawa A, Abe T, Ogata H, Hisamatsu T; Collaborators of the Study. Naganuma M, et al. J Gastroenterol. 2025 Jan 30. doi: 10.1007/s00535-025-02216-0. Online ahead of print. J Gastroenterol. 2025. PMID: 39883201
Leucine-rich alpha-2 glycoprotein in combination with C-reactive protein for predicting endoscopic activity in Crohn's disease: a single-centre, cross-sectional study.
Takada Y, Kiyohara H, Mikami Y, Taguri M, Sakakibara R, Aoki Y, Nanki K, Kawaguchi T, Yoshimatsu Y, Sugimoto S, Sujino T, Takabayashi K, Hosoe N, Ogata H, Kato M, Iwao Y, Nakamoto N, Kanai T. Takada Y, et al. Among authors: kiyohara h. Ann Med. 2025 Dec;57(1):2453083. doi: 10.1080/07853890.2025.2453083. Epub 2025 Jan 17. Ann Med. 2025. PMID: 39823192 Free PMC article.
Quality of palliative radiotherapy assessed using quality indicators: a multicenter survey†.
Saito T, Shikama N, Takahashi T, Nakamura N, Mori T, Nakajima K, Koizumi M, Sekii S, Ebara T, Kiyohara H, Higuchi K, Yorozu A, Nishimura T, Ejima Y, Harada H, Araki N, Miwa M, Yamada K, Kawamoto T, Imano N, Heianna J, Nozaki M, Wada Y, Ohkubo Y, Uchida N, Watanabe M, Kosugi T, Miyazawa K, Yasuda S, Onishi H. Saito T, et al. Among authors: kiyohara h. J Radiat Res. 2024 Jul 22;65(4):532-539. doi: 10.1093/jrr/rrae048. J Radiat Res. 2024. PMID: 38923425 Free PMC article.
Ulcerative colitis-associated neoplasms often harbor poor prognostic histologic components with low detection by biopsy.
Sakakibara R, Sugimoto S, Takabayashi K, Kiyohara H, Wakisaka Y, Kaieda Y, Kawaida M, Yoshimatsu Y, Sujino T, Hosoe N, Kato M, Shimoda M, Mikami Y, Iwao Y, Kanai T. Sakakibara R, et al. Among authors: kiyohara h. Intest Res. 2024 Oct;22(4):428-438. doi: 10.5217/ir.2024.00006. Epub 2024 May 7. Intest Res. 2024. PMID: 38712359 Free PMC article.
Efficacy of Dose Escalation of Oral 5-Aminosalicylic Acid for Ulcerative Colitis With a Mayo Endoscopic Subscore of 1: An Open Label Randomized Controlled Trial.
Fukuda T, Aoki Y, Kiyohara H, Yokoyama A, Nakazawa A, Yoshimatsu Y, Sugimoto S, Nanki K, Mikami Y, Fukuhara K, Mizuno S, Sujino T, Mutaguchi M, Takabayashi K, Morohoshi Y, Hosoda Y, Ogata H, Iwao Y, Naganuma M, Kanai T. Fukuda T, et al. Among authors: kiyohara h. Inflamm Bowel Dis. 2024 Apr 24:izae088. doi: 10.1093/ibd/izae088. Online ahead of print. Inflamm Bowel Dis. 2024. PMID: 38655866
Recent steroid use and the relapse risk in ulcerative colitis patients with endoscopic healing.
Fukuda T, Yamazaki H, Miyatani Y, Sawada T, Shibuya N, Fukuo Y, Kiyohara H, Morikubo H, Tominaga K, Kakimoto K, Imai T, Yaguchi K, Yamamoto S, Ando K, Nishimata N, Yoshihara T, Andoh A, Hibi T, Matsuoka K; IBD Terakoya Group. Fukuda T, et al. Among authors: kiyohara h. Aliment Pharmacol Ther. 2024 Jul;60(1):43-51. doi: 10.1111/apt.18013. Epub 2024 Apr 23. Aliment Pharmacol Ther. 2024. PMID: 38651779
Real-world NUDT15 genotyping and thiopurine treatment optimization in inflammatory bowel disease: a multicenter study.
Makuuchi M, Kakuta Y, Umeno J, Fujii T, Takagawa T, Ibuka T, Miura M, Sasaki Y, Takahashi S, Nakase H, Kiyohara H, Tominaga K, Shimodaira Y, Hiraoka S, Ueno N, Yanai S, Yoshihara T, Kakimoto K, Matsuoka K, Hayashi R, Nanjo S, Iwama I, Ishiguro Y, Chiba H, Endo K, Kagaya T, Fukuda T, Sakata Y, Kudo T, Takagi T, Takahashi K, Naganuma M, Shinozaki M, Ogata N, Tanaka H, Narimatsu K, Miyazaki H, Ishige T, Onodera M, Hashimoto Y, Nagai H, Shimoyama Y, Naito T, Moroi R, Shiga H; Post-MENDEL study group; Kinouchi Y, Andoh A, Hisamatsu T, Masamune A. Makuuchi M, et al. Among authors: kiyohara h. J Gastroenterol. 2024 Jun;59(6):468-482. doi: 10.1007/s00535-024-02099-7. Epub 2024 Apr 8. J Gastroenterol. 2024. PMID: 38589597 Free PMC article.
366 results